About: covid:PMC7244257

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7244257 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Einsele, Hermann Zweegman, Sonja Moreau, Philippe Avet-Loiseau, Hervé Boccadoro, Mario Cook, Gordon Dimopoulos, Meletios Engelhardt, Monika Gay, Francesca Hajek, Roman Mateos, Maria-Victoria Ntanasis-Stathopoulos, Ioannis Sonneveld, Pieter Terpos, Evangelos Ludwig, Heinz San Miguel, Jesus Vangsted, Annette van de Donk, Niels
is schema:about of	named entity 'Myeloma' named entity 'COVID-19 pandemic' named entity 'immunocompromised state' named entity 'COVID' named entity 'severe infections' named entity 'lenalidomide' named entity 'renal failure' named entity 'Antithrombosis' named entity 'COVID' named entity 'clinical trial' named entity 'radiotherapy' named entity 'COVID-19' named entity 'nasopharyngeal swab' named entity 'hematological' named entity 'Germany' named entity 'COVID' named entity 'dexamethasone' named entity 'incurable disease' named entity 'LMWH' named entity 'myeloma' named entity 'comorbidities' named entity 'health professionals' named entity 'hypercoagulation' named entity 'palliation' named entity 'SARS-CoV-2' named entity 'daratumumab' named entity 'myeloma' named entity 'intravenous' named entity 'health care professionals' named entity 'ASCT' named entity 'Vaccination' named entity 'lenalidomide' named entity 'anti-viral drugs' named entity 'SARS-CoV-2' named entity 'asymptomatic' named entity 'immunological response' named entity 'SARS-CoV-2' named entity 'COVID-19 pandemic' named entity 'clinical experience' named entity 'tocilizumab' named entity 'stem cell' named entity 'Dexamethasone' named entity 'Renal impairment' named entity 'COVID-19 pandemic' named entity 'daratumumab' named entity 'infection' named entity 'PCR' named entity 'COVID' named entity 'Europe' named entity 'vaccination' named entity 'COVID' named entity 'infection' named entity 'myeloma' named entity 'Surgical masks' named entity 'elotuzumab' named entity 'COVID-19 infection' named entity 'anemia' named entity 'steroids' named entity 'refractory' named entity 'cord blood' named entity 'adverse event' named entity 'COVID' named entity 'long-term' named entity 'venous thromboembolism' named entity 'ASCT' named entity 'out-patient' named entity 'infection' named entity 'ASCT' named entity 'air via coughs' named entity 'cardiovascular disease' named entity 'pathogens' named entity 'immunotherapy' named entity 'tocilizumab' named entity 'signs and symptoms' named entity 'monoclonal antibody' named entity 'infection' named entity 'SARS-CoV-2' named entity 'myeloma' named entity 'stay at home' named entity 'clinical trials' named entity 'ASCT' named entity 'high-risk'

Attributes

Values

Creator

Einsele, Hermann
Zweegman, Sonja
Moreau, Philippe
Avet-Loiseau, Hervé
Boccadoro, Mario
Cook, Gordon
Dimopoulos, Meletios
Engelhardt, Monika
Gay, Francesca
Hajek, Roman
Mateos, Maria-Victoria
Ntanasis-Stathopoulos, Ioannis
Sonneveld, Pieter
Terpos, Evangelos
Ludwig, Heinz
San Miguel, Jesus
Vangsted, Annette
van de Donk, Niels

is schema:about of

named entity 'Myeloma'
named entity 'COVID-19 pandemic'
named entity 'immunocompromised state'
named entity 'COVID'
named entity 'severe infections'
named entity 'lenalidomide'
named entity 'renal failure'
named entity 'Antithrombosis'
named entity 'COVID'
named entity 'clinical trial'
named entity 'radiotherapy'
named entity 'COVID-19'
named entity 'nasopharyngeal swab'
named entity 'hematological'
named entity 'Germany'
named entity 'COVID'
named entity 'dexamethasone'
named entity 'incurable disease'
named entity 'LMWH'
named entity 'myeloma'
named entity 'comorbidities'
named entity 'health professionals'
named entity 'hypercoagulation'
named entity 'palliation'
named entity 'SARS-CoV-2'
named entity 'daratumumab'
named entity 'myeloma'
named entity 'intravenous'
named entity 'health care professionals'
named entity 'ASCT'
named entity 'Vaccination'
named entity 'lenalidomide'
named entity 'anti-viral drugs'
named entity 'SARS-CoV-2'
named entity 'asymptomatic'
named entity 'immunological response'
named entity 'SARS-CoV-2'
named entity 'COVID-19 pandemic'
named entity 'clinical experience'
named entity 'tocilizumab'
named entity 'stem cell'
named entity 'Dexamethasone'
named entity 'Renal impairment'
named entity 'COVID-19 pandemic'
named entity 'daratumumab'
named entity 'infection'
named entity 'PCR'
named entity 'COVID'
named entity 'Europe'
named entity 'vaccination'
named entity 'COVID'
named entity 'infection'
named entity 'myeloma'
named entity 'Surgical masks'
named entity 'elotuzumab'
named entity 'COVID-19 infection'
named entity 'anemia'
named entity 'steroids'
named entity 'refractory'
named entity 'cord blood'
named entity 'adverse event'
named entity 'COVID'
named entity 'long-term'
named entity 'venous thromboembolism'
named entity 'ASCT'
named entity 'out-patient'
named entity 'infection'
named entity 'ASCT'
named entity 'air via coughs'
named entity 'cardiovascular disease'
named entity 'pathogens'
named entity 'immunotherapy'
named entity 'tocilizumab'
named entity 'signs and symptoms'
named entity 'monoclonal antibody'
named entity 'infection'
named entity 'SARS-CoV-2'
named entity 'myeloma'
named entity 'stay at home'
named entity 'clinical trials'
named entity 'ASCT'
named entity 'high-risk'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software